Keratin 5 polymorphism in PPK patients C linica/ and laboratory study KERATIN 5 ASSOCIATED RESTRICTION FRAGMENT LENGTH POLYMORPHISM IN PATIENTS WITH PALMOPLANTAR KERATODERMA OF UNNA-THOST TYPE S.Tomic, R.Komel, A.Kansky and M.Blumenberg ABSTRACT Hereditary palmoplantar keratodermas of the Unna-Thost type (HPPK-UT) are relatively frequent among the Slovenian and Croatian population. Members of two Slovenian families (33 persons altogether) were investigated for RFLP (restriction fragment length polymorphism). RFLP of the patients DNA was studied by applying the following endonucleases: Hind III, Taq I, EcoRI, Sac I, BamHl and Msp I. Only digestion with Msp I produced four polymorphic fragments which were identified asa, b, c and d alleles ofkeratin 5. 14 out of 15 affected persons expressed the d allele in a heterozygous or homozygous way. In a number of unaffected members the d allele was also present. KEYWORDS Keratin 5, restrictionfragment length polymorphism, pa/moplantar keratoderma , Unna-Thost type, Msp I INTRODUCTION Hereditary palmoplantar keratodermas (HPPK) are disorders of keratinization characterized by a thickened homy layer on palms and so les. V arious types of HPPK are distinguishable by clinical symptoms , associated abnormalities and the mode of inheritance. HPPK of the Unna-Thost (UT) type is the most frequent, its prevalence is 1:40.000 in Northem Ireland (1), 1:12.000 in Slovenia (2) and 1:25.000 in Croatia (3). In Sweden at Westerbotten county a prevalence of 1:300 among adolescents (4) and at Norbotten county of 1:200 among school children were registered (5). The cause of HPPK - UT is not known, however dominant inheritance and circumscri bed distribu tion allow the possibility that this disease is due to a mutation in a structural protein specialll y expressed in palmar and plan tar epidermis. Likely candidates for such proteins are keratins. Keratins are inte1mediate filament proteins which constitute the cytoskeleton of all epithelial cells. Over 30 such proteins are known and each is coded by a separate gene. They can be subdivided into two distinct classes on the basis of their migration in two dimensional electrophoresis. theirexpression in different cell types and of their sequence homology (6). Type I keratins (KlO - K19 are smaller (40-56.5 kD) and This work was supported by the V .S . Joint Board project HSS JF 915 "Genetic Studies on Hereditary Disorders of Keratinization " which is gratefully acknoYi-"ledged. 114 acta dermatovenerologica A.P.A . Vol 1, 92 , No 4 Keratin 5 polymorphism in PPK patients relatively acidic (pI 4.5-5.5), whereas type II keratins (Kl - K9) are larger (53-68 kD) and more basic (pI 5.5-7.5). Usually keratins are expressed as specific pairs consisting of one type I and one type II polypeptide, both of which are essential for filament formati on (7 ,8) and as such characterize biochemically the type of epithelial differentiation. Por example KS and K 14 are synthesized in the basal cell layer of ali stratified squamous epithelia, while in the course of stratification differentiating epidermal cells express Kl and K 10. Suprabasal maturing cells ofnonkeratinizing squamous epithelia express K4 and K 13, while in a number of epidermal skin diseases K6 and K16 are expressed suprabasally (9). Expression ofkeratins is often much greater in differentiating cells than in basal cells (10). Elucidating ofkeratin functions has been hampered by Jack of known genetic disease involving an identified keratin mutation. During the last few years however important new data concerning the genetics of keratin were accumulated. Hereditary epidermolysis buli osa simplex (EBS) arises from basal celi cytolysis. Coulombe et al. (11) demonstrated that a perturbation of basal celi keratin filament network was responsible for the clinical manifestations of EBS. In two patients with EBS of Dowling-Meara type a point mutation in thecritical region ofthe K14 gene was observed: Arg 125 to Cys mutation. The same genetic defect in transfected keratinocytes resulted in a disruptedkeratinnetworkfo1mation and in a perturbarted filament assembly. In a family with EBS ofKoebner type Bonifas et al. (12) were able to map the defect to chromosome 17 by !od score calculation and to identify the mu tati on in the base pair 3542 of the responsible gene. Lane et al. (13) described in a family with EBS of Dowling-Meara type a Glu to Gly mutation in the helix- termination peptide of keratin 5. It is worth to mention that Vassar et al. (14) by inse1ting a truncated Kl4 protein (missing 135 amino acid residues at the C-terminal) into mice succeeded to produce epide1mal blistering in transgenic offspring which was similar to EBS lesions. The micromorphologic investigation revealed a disruption of keratin network assembly, presence of clumped keratin and cytolysis of basal cells. Complementary in vitro filament assembly studies on bacterially produced human KS, Kl4, and the truncated mutant K 14 showed that addition of as little as 1 % ofthe mutant K14 to the assembly mixture caused a detectable alteration in filament formation (14). Purther transgenic studies confirmed the dominant behavior of mutations such as the above mutation in K14, and provided strong evidences as to which human skin diseases might be candidates for natura! mutations not only in K14 but also in other genes such as KS. More recently another hereditary epidermal disorder has been traced to mutations in keratin genes: epide1molytic hyperkeratosis (EH) which is due to mutationsintheKl andKlOkeratingenes( 15, 16, 17, 18). acta dermatovenerologica A.P A. Vol 1, 92 . No 4 Therefore we examined the possibilitiy that HPPK-UT mutation maps in the type II keratin gene cl uster, by examining genetic linkage betweenHPPK-UT and a pol ymorphic mar ker in the KS keratin gene. The human KS keratin gene encodes a 58 kD protein which belongs to the basic Type II keratin family. The protein is polymorphic and at least two allelic variants were detected (19,20). The gene itself is approximately 5 kb long, contains nine exons and is located on the chromosome 12 (21,22). In the present study we are reporting some evidence about polymorphism within the coding region of the gene itself. MATERIALS AND METHODS Blood samples were taken from members of two Slovenian families affected by HPPK-UT as well as from non-affected and nonrelated controls. Eight patients and nine non-affected relatives belonged to family SO from Eastern Slovenia (Celje area). Another seven patients and nine non-affected persons were members of family PA from Westem Slovenia (Ajdovščina area). High molecular weight DNA was prepared from nuclei of leukocytes. Samples of the whole blood were first lysed by adding an equal volume of solution containing 0.32 M sucrose, 10 mM Tris-HCl (pH 7.4), 5 mM MgCl 2 and 1 % Tri ton X-100. The nuclei were then collected by centrifugation and theDNA was purified by incubating ovemight at 37°C in a buffer solution of 10 mM Tris-HCI, 400 mM NaCl and 2 mMEDT A (pH 8.2) containing 1 % sodi um dodecyl sulfate (SDS) and 0.15 mg/ml Proteinase K. Proteins were salted out by 6M NaCl and DNA was precipitated from the supernatant by adding two volumes of ice-cold absolute ethanol (23). Digestions of the DNA with restriction endonucleases such as Hind III, Taq I, Eco RI, Sac I, Bam HI and Msp I were canied out observing the conditions recommended by the manufacturer (Gibco BRL). The digested DNAs were fractioned by electrophoresis in 0.8 % agarose gel. After electrophoresis the digested DNA was denatured in the gel by submersing in 0.4MNaOH and blotted onto nylon membranes (NEN DuPont) by capillary transfer (24). PKA 1 probe containing a 1.68 bp DNA fragment of the KS gene (PKA 1 -bprobe) waslabelled withalpha/32P/-dCTPto aspecific activity of3x 108 cpm/µg by random primer extensionmethod (25) using the Amersham Multiprime labelling kit. Membranes with restricted and denatured DNA fragments were hybridized to radieJactively labelled PKA 1-b probe in a standard hybridization solution containing 50 % formamide 115 Keratin 5 polymorphism in PPK patients Figure 1: Southern blots of restricted DNAs as individualized by autoradiography. Familly SO. (Amersham Hybridization Protocols) at 42°C for 48 hours. After hybridization the membranes were washed once in 2xSSC/0.1 % SDS for 5 minutes at room temperature, and a second tirne in the same solution at 65°C for 15 minutes. Visualization was performed by autoradiography using a X-ray film (X-Omat, Kodak), after two and seven days exposure times. RESULTS In order to search for KS-gene polymorphisms first six DNA samples from unaffected unrelated individuals were Figure 2: Southern blots of restricted DNAs as visualized by autoradiography. F amilly F A. 116 digested with six different restriction endonucleases and hybridized to PKA 1 probe. Five of the enzymes gave non- polymorphic band pattems, but only digestion with Msp I produced polymorphic fragments of which the total number was four and with the lengths of 8.7, 7.2, 6.4 and 3.2 kb respectively. The fragments were assigned asa, b, c and d alleles (Figures 1 and 2). Two families with hereditary PKK were then screened for the presence of Msp I RFLP. The genotypes of both the families are presented. In the family SO (Eastem Slovenia) the eight affectedmembers displayed b/d and a/dheterozigous or d/d homozigous genotype (Fig 3). In the farnily FA (Westem Slovenia), six out of seven affected members expressed the d allele. Details are presented in Figure 4. DISCUSSION It is difficult to find out exactl y who was the first to describe the polymorphism of keratin molecules. It seems however that the introduction of sodium dodecyl sulfate polyacrylarnide gel electrophoresis as well as of modem chromatographic methods in the protein biochemistry were helpful in achieving essential pro gress in this direction. W ild and Mische described in 1986 the occurrence of keratins K4a and K4b as well as K5a and K5b as conspicuous doublets in the stratified epithelium lining the upperdigestive tractin some individuals, while in others only one of these variants was present. They assumed that a polymorphism ofthe respective keratin genes was responsible forthis heterogeneity (26). Later on the same authors made a similar observation analyzing the keratins of human epidermis by SDS PAGE and immunoblotting: basic keratins Kla, Klb, K5a and K5b, and acidic keratins KlOa and KlOb appeared either as doublets or as one or the other variant. In rare cases other acidic keratins tentatively designated as KlOd and KlOc were also observed (20). In 1992 Korge et al. (27) confirmed the existence of the above mentioned four variants of Kl0, which represent four differently sized alleles. In order to answer the question whether these KlO variants are due to multiple genes or different alleles within the human population or are caused by different posttranslational RNA processing, they have looked for the nature of the polymorphism by analyzing respective gene sequences. Their investigation showed that the polymorphism was located in the V2 subdomain of the K 10 molecule. According to their experience the size polymorphism of the KlO gene is inherited as a normal Mendelian trait, and the differently sized products obtained by PCR amplification most likely represent different alleles of a single-copy gene per haploid genome. In our investigation we have looked for the possible existence of restrictionfragment length polymorphisms within acta dermatovenerologica A.P.A. Vol 1, 92, No 4 Keratin 5 polymorphism in PPK patients bd ab ~b Figure 3: Geneological tree and inheritance of the KS po/ymorphic a/leles infamily SO. Figure 4: Geneologica/ tree and inheritance of the KS polymorphic alleles infamily FA. the coding region of the K5 gene.Results obtained in this study indicate thatK5 is also present, like KlO, infour allelic modifications. It is interesting to mention that allele d was found in almost all persons affected with HPPK type Unna- Thost (in 14 out of 15 patients). As this allele was present also in certain unaffected individuals it can be assumed that the respective gene is not characteristic for HPPK-UT. Furthermore, in three individuals, 24, 27 and 31 of farni! y F A, the disease does not segregate with the K5 gene alleles. We concl ude from these preliminary results that the mu tati on causing HPPK-UT is probably not linked with the basic keratin genes on chromosome 12. Further investigation, in order to confirm the above results and to find possi bl y the informative pol ymorphisms associated with pathological phenotype (s), has to include much greater number of hereditary PKK cases. To define precisely the nature of the polymorphisms found in this investigation PCR amplification and sequence analyses of the DNAs should be performed. And finally, extensive analyses such as cloning and sequencing of keratin cDNAs, such as K5 and Kl4 cDNAs from skin mRNAs, in a number of patients will be needed before the etiology ofthe disease is fully understood. REFERENCES l .Ebling F .J .G., Marks R., Rook A.: Disorders of Keratinization. In: Textbook ofDermatology (Rook A., Wilkinson D.S., Eibling F.J., ChampionR.H., Burton J.C., eds.), Blackwell, Oxford 1986: pp. 1452. 2. Kansky A., Arzenšek J., Rode M., Strojan J .: Keratodermia palmoplantaris of the Unna-Thost type in Slovenia. Acta Derm. acta dermatovenerologica A.P.A. Vol 1, 92, No 4 Venereol. (Stockholm) 1984; 140-143. 3. Stanimirovic A., Kansky A.: Palmoplantar keratoderrna type Unna-Thost in Croatia. Acta Derm. lug. 1991; 18: 67-72. 4. Larsson P., Liden S.: Prevalence of skin diseases among adolescents 12-16yearsof age. ActaDerm. Venereol. (Stockholm) 1966; 60: 415-423. 117 Keratin 5 polymorphism in PPK patients 5. Bergstroem C.: Keratodermia palmaris et plantaris. Nord.Med. 1967; 78: 155-156. 6. Moll R., Franke W.W., Schiller D.L., Geiger B., Krepler R.: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cell 1982; 31: 11-34. 7. Hatzfeld M., Franke W.W .: Pair formation and promiscuity of cytokeratins: formation in vitro of heterotrophic complexes and intermediate-sized filaments by homologous and heterologous recombination of purified polypeptides. J.Cell Biol. 1985; 101: 1826-1841. 8.Eichner R., Sun T. -T., Aebi U.: Theroleofkeratin subfamilies andkeratinpairsintheformationofhumanepidermalintermediate filaments. J . Cell Biol. 1986; 102:1767-1777. 9. SunT. - T.,EichnerR. , Schermer A., Cooper D., NelsonD.W., Weiss R.A.: Classification, expression and possible mechanism of evolution of mamalian keratin of unifying model. In: The Cancer Celi (Levine A.J., Topp W.C., Van de Wonde G.F., Watson J.D., eds.) Cold Spring Harbor Laboratory, New York 1984; p. 169-176. 10. Galvin S., Loomis C., Manabe M., Dhonailly D., Sun T.T.: The major pathways of keratinocyte differentiation as defined by keratin expression: an overview. Adv. Dermatol. 1989; 4: 277-300. 11. Coulombe P.A., Hutton M.E., Letai A. et al .: Point mutations in human Keratin 14 genes of Epidermolysis bullosa simplex patients. Cell 1991; 66: 1301-11. 12. Bonifas J.M„ Rothman A.L., Epstein E.H. Jr.: Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 1991; 254: 1202-1205. 13. Lane E.B., Rugg E.L., Navsaria H. et al. : A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992; 356: 244-246. 14. Vassar R., Coulombe P.A., Degenstein R. et al.: Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 1991; 64: 365-85. 15. Yamamoto A., McGrath J.A., Judge M.R., Leigh I.M., Lane E.B., Eady R.A.J.: Selective involvementofkeratin 1 andkeratin 10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bulous congenital ichtyosiform erythroderma). J. Invest. Derm. 1992; 99/1: 19-26. 16. Compton Digiovan J.J., Santucci S.K., Kearus K.S ., Amos C.L., Abangan D.L., Korge B.P., McBride O.W., Steinert P.M., Bale S.J .: Linkage of epidermolytic hyperkeratosis to the Type II gene cluster on chromosome 12q. Nat. Genet. 1992; 1/4: 301-305. 17. Rothnagel J.A., Dominey A.M., Dempsey L.D., Longley M.A., Greenhal D.a., Gagne T.a., Hubner M. , Frenk E., Hohl D., Roop D.R.: Mutations in the rod domains ofkeratin-1 andkeratin 10 in epidermolytic hyperkeratosis. Science 1992: 257 (5073): 1128-1130. 18. Cheng J., Syder A.J., Yu Q. C., Letai A., Paller A.S., Fuchs E.: The genetic basis of epidermolytic hyperkeratosis - a disorder of differentation specyfic epidermal keratin genes. Cell 1992; 70/5: 811 -819. 19. Mieschke D., Wille G., Wild G.A.: Allele frequencies and segregation of human polymorphic keratins K4 and K5 . Am. J. Hum. Genet. 1990; 46: 548-552. 20. Mieschke D., Wild A.G.: Polymorphic keratins in human epidermis. J. Invest. Dermatol. 1987; 88: 191-197. 21. Lersch R., Stellmach V., Stocks C., Ginidice G., Fuchs E.: Isolation, sequence and expression of a human keratin K5 gene: transcriptional regulation of keratins and insights into pairwise control. Mol.Cell.Biol. 1989; 9: 3685-3697. 22. Lessin S.R., Huebner K., !sobe M ., Croce C.M., Steinert P.M.: Chromosomal mapping ofhuman keratin genes: evidence of nonlinkage. J. Invest. Dermatol. 1988; 91: 572-578. 23. Miller S.A., Dyckes D.D., Polesky H.P.: A simple s!'Jting out procedure for extracting DNA from human nucleatedcells. Nucl. Acids Res. 1988; 16: 1215. 24. Southern E.M.: Detection of specific sequences among fragments separated by gel electrophoresis. J. Mol.Biol. 1975; 98:503-517. 25 . Sambrook J., Fritsch E.F„ Maniatis T.: Molecular Cloning - A Laboratory Manual . Cold Spring Harbor Laboratory Press, New York 1989; p. 10.13-10.14. 26. Wild G.A., Mieschke D.: Variation and frequency of cytokeratin polypeptide patterns in human squamous non- keratinizing epithelium. Exp. Cell Res. 1986; 162: 114-126. 27. Korge B.P., Song-Quing G., McBride W. Mieschke D., SteinertP.M.: Extensivesize polymorphism ofthe human Keratin lOchain residuesin the C-terminal V2 subdomain due to variable numbers and sizes of glycine loops. Proc.Natl.Acad.Sci.U.S.A. 1992; 89:910-914. Authors' Addresses Siniša Tomič, chemist, Lastovska 4 , 41000 Zagreb, Croatia. Radovan Komel, Ph.D., professor of biochemistry, Head of the Medica! Center for Molecular Biology, Institute of Biochemistry, Medica! Faculty, Vrazov trg 2, 61000 Ljubljana, Slovenia. Aleksej Kansky M.D., Ph.D., professor of dermatology, Štihova 26, 61000 Ljubljana, Slovenia. Miroslav Blumenberg, Ph.D., professor of biochemistry and dermatology, R.O. Perlman, Departrnent ofDermatology, NYU Medica! Center, 550 First Ave 10016, New York, N.Y., U .S.A. 118 acta dermatovenerologica A.P.A. Vol I, 92 , No 4